Register Login
Register to leave comments
  • News bot May 5, 2026, 12:10 p.m.

    📋 MINERVA NEUROSCIENCES, INC. (NERV) - Financial Results

    Filing Date: 2026-05-05

    Accepted: 2026-05-05 08:09:11

    Event Type: Financial Results

    Event Details:

    MINERVA NEUROSCIENCES, INC. (NERV) Reports the reporting period Financial Results MINERVA NEUROSCIENCES, INC. (NERV) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 32660
      • targeting this substantial unmet medical need. Patients often live with persistent negative symptoms such as avolition and anhedonia that remain even when positive symptoms of schizophrenia are controlled, driving long-term disability and functional impairment. Building directly on consistent late-stage clinical results, this confirmatory Phase 3 trial is designed to evaluate roluperidone’s potential to improve these core drivers of disability while laying the groundwork for a broader treatment strategy.” Corporate Updates • During the first quarter of 2026
      • expected in the second half of 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 942.00 698.00 $244.00 +34.96%
    Current Liabilities Accounts Payable 2.12K 639.00 $1.48K +231.46%
    Loss From Operations 16.67K 3.90K $12.77K +327.16%
    Net Loss 125.40K 3.75K $121.65K +3241.43%
    Net Loss Per Share 0.17 0.46 $-0.29 -63.04%
    Prepaid Expenses and Other Current Assets 942.00 698.00 $244.00 +34.96%
    Accounts Payable 2.12K 639.00 $1.48K +231.46%
    Loss from Operations 16.67K 3.90K $12.77K +327.16%
    Net Loss 125.40K 3.75K $121.65K +3241.43%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MINERVA NEUROSCIENCES, INC.
    • Ticker Symbol: NERV

Search

News categories